Entry |
|
Symbol |
CDKN2B, CDK4I, INK4B, MTS2, P15, TP15, p15INK4b
|
Name |
(RefSeq) cyclin dependent kinase inhibitor 2B
|
KO |
K04685 | cyclin-dependent kinase inhibitor 2B |
|
Organism |
|
Pathway |
hsa05166 | Human T-cell leukemia virus 1 infection |
|
Network |
|
Element |
N00088 | Amplified MYC to p15-cell cycle G1/S |
N00495 | HTLV-1 Tax to p15-cell cycle G1/S |
|
Disease |
H00015 | Malignant pleural mesothelioma |
H02434 | Diffuse large B-cell lymphoma, not otherwise specified |
|
Brite |
KEGG Orthology (KO) [BR:hsa00001]
09130 Environmental Information Processing
09132 Signal transduction
04350 TGF-beta signaling pathway
1030 (CDKN2B)
04068 FoxO signaling pathway
1030 (CDKN2B)
09140 Cellular Processes
09143 Cell growth and death
04110 Cell cycle
1030 (CDKN2B)
04218 Cellular senescence
1030 (CDKN2B)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
1030 (CDKN2B)
05203 Viral carcinogenesis
1030 (CDKN2B)
09162 Cancer: specific types
05226 Gastric cancer
1030 (CDKN2B)
05222 Small cell lung cancer
1030 (CDKN2B)
09172 Infectious disease: viral
05166 Human T-cell leukemia virus 1 infection
1030 (CDKN2B)
09167 Endocrine and metabolic disease
04934 Cushing syndrome
1030 (CDKN2B)
|
SSDB |
|
Motif |
|
Other DBs |
|
LinkDB |
|
Position |
9:complement(22002903..22009313)
|
AA seq |
138 aa
MREENKGMPSGGGSDEGLASAAARGLVEKVRQLLEAGADPNGVNRFGRRAIQVMMMGSAR
VAELLLLHGAEPNCADPATLTRPVHDAAREGFLDTLVVLHRAGARLDVRDAWGRLPVDLA
EERGHRDVAGYLRTATGD |
NT seq |
417 nt +upstreamnt +downstreamnt
atgcgcgaggagaacaagggcatgcccagtgggggcggcagcgatgagggtctggccagc
gccgcggcgcggggactagtggagaaggtgcgacagctcctggaagccggcgcggatccc
aacggagtcaaccgtttcgggaggcgcgcgatccaggtcatgatgatgggcagcgcccgc
gtggcggagctgctgctgctccacggcgcggagcccaactgcgcagaccctgccactctc
acccgaccggtgcatgatgctgcccgggagggcttcctggacacgctggtggtgctgcac
cgggccggggcgcggctggacgtgcgcgatgcctggggtcgtctgcccgtggacttggcc
gaggagcggggccaccgcgacgttgcagggtacctgcgcacagccacgggggactga |